Effect of a Monoclonal Antibody against Interleukin-4 on Suppression of Antigen-Induced Arthritis in Mice by Oral Administration of the Inducing Antigen
- 1 August 1998
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 187 (2) , 139-144
- https://doi.org/10.1006/cimm.1998.1328
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 37 references indexed in Scilit:
- Suppression of antigen‐induced arthritis in lewis rats by oral administration of type ii collagenArthritis & Rheumatism, 1995
- Published by American Association for the Advancement of Science (AAAS) ,1994
- Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.The Journal of Experimental Medicine, 1992
- Suppression of chronic antigen-induced arthritis in rats by a monoclonal antibody against the T cell receptor αβCellular Immunology, 1992
- Depletion of alpha/beta T cells by a monoclonal antibody against the alpha/beta T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in rats.The Journal of Experimental Medicine, 1992
- Treatment of collagen‐induced arthritis in rats with a monoclonal antibody against the α/β T cell antigen receptorArthritis & Rheumatism, 1991
- Could specific oral tolerance be a therapy for autoimmune disease?Immunology Today, 1990
- The regulation of immune responses to dietary protein antigensImmunology Today, 1987
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985
- Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1Nature, 1985